109 related articles for article (PubMed ID: 32275122)
1. Thyroid cancer histological subtypes based on tumor size: National perspective.
Al-Qurayshi Z; Foggia MJ; Pagedar N; Lee GS; Tufano R; Kandil E
Head Neck; 2020 Sep; 42(9):2257-2266. PubMed ID: 32275122
[TBL] [Abstract][Full Text] [Related]
2. Risk and survival of patients with medullary thyroid cancer: National perspective.
Al-Qurayshi Z; Khadra H; Chang K; Pagedar N; Randolph GW; Kandil E
Oral Oncol; 2018 Aug; 83():59-63. PubMed ID: 30098780
[TBL] [Abstract][Full Text] [Related]
3. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Risk of Metastatic Thyroid Cancers and Management Outcomes: A National Perspective.
Al-Qurayshi Z; Sullivan CB; Pagedar N; Lee GS; Tufano R; Kandil E
Laryngoscope; 2021 Jan; 131(1):237-244. PubMed ID: 32574405
[TBL] [Abstract][Full Text] [Related]
6. Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers.
Rajjoub SR; Yan H; Calcatera NA; Kuchta K; Wang CE; Lutfi W; Moo-Young TA; Winchester DJ; Prinz RA
Surgery; 2018 May; 163(5):1134-1143. PubMed ID: 29426618
[TBL] [Abstract][Full Text] [Related]
7. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
8. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of follicular thyroid carcinoma in children and adolescents: A study of 30 cases.
Spinelli C; Rallo L; Morganti R; Mazzotti V; Inserra A; Cecchetto G; Massimino M; Collini P; Strambi S
J Pediatr Surg; 2019 Mar; 54(3):521-526. PubMed ID: 29935896
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cm.
Lodewijk L; Kluijfhout WP; Kist JW; Stegeman I; Plukker JT; Nieveen van Dijkum EJ; Bonjer HJ; Bouvy ND; Schepers A; de Wilt JH; Netea-Maier RT; van der Hage JA; Burger JW; Ho G; Lee WS; Shen WT; Aronova A; Zarnegar R; Benay C; Mitmaker EJ; Sywak MS; Aniss AM; Kruijff S; James B; Grogan RH; Brunaud L; Hoch G; Pandolfi C; Ruan DT; Jones MD; Guerrero MA; Valk GD; Borel Rinkes IH; Vriens MR
Langenbecks Arch Surg; 2016 May; 401(3):365-73. PubMed ID: 27013326
[TBL] [Abstract][Full Text] [Related]
13. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
[TBL] [Abstract][Full Text] [Related]
14. Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer.
Al-Qurayshi Z; Shama MA; Randolph GW; Kandil E
Endocr Relat Cancer; 2017 May; 24(5):221-226. PubMed ID: 28249964
[TBL] [Abstract][Full Text] [Related]
15. Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines.
Dyhdalo KS; Chute DJ
Cancer Cytopathol; 2018 Jun; 126(6):397-405. PubMed ID: 29579362
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Surgical Extent and Prognosis in Node-Negative, Early-Stage Papillary Thyroid Carcinoma Originating in the Isthmus.
Lim ST; Jeon YW; Suh YJ
World J Surg; 2016 Feb; 40(2):344-9. PubMed ID: 26446448
[TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
Panigrahi B; Roman SA; Sosa JA
Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.
Griniatsos J; Tsigris C; Kanakis M; Kaltsas G; Michail O; Dimitriou N; Argyrakopoulou G; Delladetsima I; Kyriakou V; Syriou V; Alexandraki K; Pikoulis E; Giannopoulos A; Kouraklis G; Diamanti-Kandaraki E; Felekouras E
Anticancer Res; 2009 Dec; 29(12):5163-9. PubMed ID: 20044632
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry.
Cramer JD; Fu P; Harth KC; Margevicius S; Wilhelm SM
Surgery; 2010 Dec; 148(6):1147-52; discussion 1152-3. PubMed ID: 21134545
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
Murthy SP; Balasubramanian D; Subramaniam N; Nair G; Babu MJC; Rathod PV; Thankappan K; Iyer S; Vijayan SN; Prasad C; Nair V
Head Neck; 2018 Jun; 40(6):1214-1218. PubMed ID: 29417654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]